Lexaria Bioscience Corp. (LEXX)
NASDAQ · Healthcare
Lexaria Bioscience Corp. Gross Profit 2016–2025
Lexaria Bioscience Corp. annual/quarterly gross profit history and growth rate from 2016 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Lexaria Bioscience Corp. gross profit for the quarter ending February 28, 2026 was 20000, a 88.51% decrease year-over-year.
- Lexaria Bioscience Corp. gross profit for the twelve months ending February 28, 2026 was 368000, a 33.89% decrease year-over-year.
- Lexaria Bioscience Corp. annual gross profit for 2025 was 703203, a 53.05% increase from 2024.
- Lexaria Bioscience Corp. annual gross profit for 2024 was 459456, a 135.97% increase from 2023.
- Lexaria Bioscience Corp. annual gross profit for 2023 was 194708, a 6.08% increase from 2022.
- Lexaria Bioscience Corp. annual gross profit for 2022 was 183556.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Lexaria Bioscience Corp. Gross Profit — FAQ
Lexaria Bioscience Corp. (LEXX) gross profit over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Lexaria Bioscience Corp.'s gross profit?
Lexaria Bioscience Corp. (LEXX) reported gross profit of $703,203 for fiscal 2025.
Where can I see LEXX's gross profit history?
The chart and table above show Lexaria Bioscience Corp.'s gross profit by year and by quarter, including the growth rate.